We serve Chemical Name:3-Methyl-5-(trifluoromethyl)aniline CAS:96100-12-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Methyl-5-(trifluoromethyl)aniline
CAS.NO:96100-12-8
Synonyms:Benzenamine, 3-methyl-5-(trifluoromethyl)-;Benzenamine, 3-methyl-5-trifluoromethyl;3-Methyl-5-(trifluoromethyl)aniline;3-Amino-5-methylbenzotrifluoride;3-Methyl-5-trifluoromethylaniline;MFCD01631580;3-methyl-5-amino benzotrifluoride;Benzenamine,3-methyl-5-trifluoromethyl
Molecular Formula:C8H8F3N
Molecular Weight:175.151
HS Code:2921430090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:203.3±40.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.481
PSA:26.02000
Exact Mass:175.060883
LogP:2.85
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811
Packing Group:
Contact us for information like Benzenamine, 3-methyl-5-(trifluoromethyl)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenamine,3-methyl-5-trifluoromethyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Methyl-5-(trifluoromethyl)aniline Use and application,3-Methyl-5-trifluoromethylaniline technical grade,usp/ep/jp grade.
Related News: Novak noted that the research team did see some improvement in standard brain function tests given to a smaller group of trial participants who had actually been diagnosed with Alzheimer’s. 3-Methyl-5-(trifluoromethyl)aniline manufacturer Novak noted that the research team did see some improvement in standard brain function tests given to a smaller group of trial participants who had actually been diagnosed with Alzheimer’s. 3-Methyl-5-(trifluoromethyl)aniline supplier In October 2020, the Trump administration ordered $375 million worth of Lilly’s COVID-19 antibody therapy bamlanivimab, which is manufactured at the Branchburg plant. 3-Methyl-5-(trifluoromethyl)aniline vendor Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL. 3-Methyl-5-(trifluoromethyl)aniline factory In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.
